DGH v Tertiary Intervention Is there really a conflict? “The BCIS Perspective” Dr Martyn Thomas Kings College Hospital BCIS President.

Slides:



Advertisements
Similar presentations
Exploring opportunities for health research collaborations between Australia and the UK Professor Nigel Mathers & Dr Susan Nancarrow Institute of General.
Advertisements

The Nebraska Heart Institute Heart Hospital Influencing and Shaping the Future of Health Care.
BCIS Returns 1998 (Oct 1999) BCIS Audit Returns of Interventional Procedures 1998 Leicester, October 1999 Mark de Belder (Audit Secretary, BCIS) on behalf.
BCIS Audit Returns of Interventional Procedures 2000 Mark de Belder BCIS UK National Audit Officer on behalf of Council of the British Cardiovascular Intervention.
Fylde Coast Integrated Diabetes Care
Enhanced Peri-Operative Care for High-risk patients Introductory slide-set.
Coronary Revascularisation in Patients With Diabetes Mellitus Dr Rod Stables The Cardiothoracic Centre Liverpool UK.
“Adjunctive Therapy” Non ST segment elevation ACS Dr M R Thomas King’s College Hospital. Advanced Angioplasty 2002.
BCIS Audit Returns of Interventional Procedures 2001 Edinburgh 2002 Mark de Belder BCIS National Audit Officer on behalf of Council of the British Cardiovascular.
ARTS I & II Keith D Dawkins Southampton University Hospital.
Setting up a STEMI PCI Programme in the UK: Implications for the cath lab workforce Rob Henderson Trent Cardiac Centre Nottingham Chair, BCS Working Group.
Emergency Unit Management: a guide to better practice Basil Bonner Head: Emergency Unit Milnerton Medi-Clinic.
Coaching For Quality Dec 7th 2012
Professor Roger Boyle CBE National Director for Heart Disease and Stroke Department of Health PCI in the UK: Fit for service? A view from the Department.
Interventional Registries The Audit and Research Potential of the BCIS CCAD Registry Peter F Ludman.
“Randomised trials of CABG v PCI are no longer possible and cannot represent real life practice.” Dr Rod Stables The Cardiothoracic Centre Liverpool UK.
What Do We Mean By Quality In PCI Institutional Requirements Dr Bernard Prendergast John Radcliffe Hospital, Oxford.
PAYMENT BY RESULTS The Effect of National Tariffs on Coronary Revascularisation Stephen Holmberg Sussex Cardiac Centre.
Trans-catheter Aortic Valve Replacement: a UK update. Dr Martyn Thomas Guys and St Thomas’ Hospital.
30 years of medical mistakes – what has changed? Miss J.E.Porter FRCS FCEM.
“Tertiary Centres are Obsolete” Dr Neil Sulke or ‘The Patsy’ In possibly his last ever presentation to BCIS Competing interests: What’s best for our patients.
Stent or Surgery: What is Best for a Woman ? Dr R H Stables Cardiothoracic Centre Liverpool UK.
PCI Models: Gloucestershire Nick West Consultant Cardiologist.
BACR Standards: A Useful Tool? Jennifer George / Michelle Bull SWL Cardiac and Stroke Network.
BCIS Annual Meeting London January 2006 Dr Bernard Prendergast DM FRCP Wythenshawe Hospital Manchester UK Primary Angioplasty for Acute MI Who are the.
Basic Economic Analysis David Epstein, Centre for Health Economics, York.
Minimise the damage – Pre- and Post-conditioning Dr Derek J Hausenloy The Hatter Cardiovascular Institute, University College London, UK. Myocardial Recovery.
NHS – Enabling Change Improving processes and adding value 5th February 2015 Ian Quinnell Associate Director for Programme Management and Service Improvement.
Private General Practice an overview Dr Harry Trakoshis MBChB MRCGP DOH for Visiting GP group September 2011.
Does Openness Improve Outcome ? The North-West Quality Improvement Program Dr R H Stables Cardiothoracic Centre Liverpool.
DELIVERING PCI THROUGH THE CLINICAL NETWORK DR JIM HALL THE JAMES COOK UNIVERSITY HOSPITAL MIDDLESBROUGH.
What’s happened in 2007 and why? Mark de Belder President British Cardiovascular Intervention Society.
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
Top Trial Cheats Dr Rod Stables The Cardiothoracic Centre Liverpool UK No Conflicts of Interest to Declare.
Unresolved issues with Drug-eluting Stents Stent Thrombosis Advanced Angioplasty 2007 Dan Blackman Yorkshire Heart Centre.
Glycoprotein IIb/IIIa inhibitors and bivalirudin: under utilised? Azfar Zaman Freeman Hospital Newcastle-upon-Tyne.
AA 2008 Session III: STEMI The UK data Mark de Belder The James Cook University Hospital Middlesbrough.
A MODEL FOR CO-OPERATION - some inconvenient truths Mark Signy Worthing and Brighton.
2003 data: Ludman BCIS Audit Returns Adult Interventional Procedures 2003 Peter F Ludman BCIS National Audit Officer On behalf of British Cardiovascular.
How will we know whether this technology is appropriate? OR New procedures, NICE and Specialist Societies Bruce Campbell Chairman NICE Interventional Procedures.
Coronary Revascularisation: the DoH View Dr Roger Boyle National Director for Heart Disease.
PCI v CABG Dr Rod Stables The Cardiothoracic Centre Liverpool UK.
Ken Timmis MBE JP LCIE President Heart Care Partnership (UK) Patient Representative Black Country Cardiovascular Network Board Chairman Wolverhampton Coronary.
28 Jan Advanced Angioplasty 2005 Staffing of diagnostic and interventional catheter labs in the DGH setting Dr David Hackett 28 Jan 2005.
BCIS Autumn Meeting, Crewe, September 2008 Transcatheter Aortic Valve Intervention: How do we take it forward in the UK? Mark de Belder President, British.
The Leeds Teaching Hospitals NHS Trust PHARMACOLOGY IN ACS OVERVIEW OF THE DATA : PRACTICAL ADVICE JIM McLENACHAN, LEEDS. 25 th January, 2007.
Dr Martyn Thomas Kings College Hospital Primary angioplasty “A UK Experience” “The UK experience”
BCIS Audit Returns Adult Interventional Procedures Jan 2005 to Dec 2005 Peter F Ludman BCIS National Audit Officer On behalf of British Cardiovascular.
Reflections on NCEPOD: Knowing the Risk Norman S Williams President December 2011.
Cardiac Diagnostic Imaging Services Dr Andrew Wood UHW Cardiff 14 th July 2010.
HRG4: Impact on Arrhythmia Care Donna Elliott-Rotgans Cardiology Service Manager UCLH / The Heart Hospital.
St Asaph - November 2015 Dr Richard Anderson Consultant Cardiologist Senior Lecturer University Hospital of Wales, Cardiff, UK Wales Audit Data
Novel Trial Design Focus - Left Main and “All Comers” DES Studies: All-Comers Studies. Interventional View Jeffrey J. Popma, MD Director, Innovations in.
Engaging and Supporting Surgical Research: Clinical Research Networks
Clinical Trial Design for Second Generation TAVI - Academic View
Prof. Dr. med. Sigmund Silber Cardiology Practice and Hospital
OUS Data: What does the CE Mark Really Mean?
Talk Title SURGICAL BACK-UP IS NOT REQUIRED FOR PRIMARY PCI
On-Site Surgical Back-up is ‘Critically’ Important for PCI!
Debate: What Does the Future Hold for the Treatment of Unprotected Left Main Disease? More PCI No More Routine Surgery Ron Waksman, MD, FACC Washington.
Understanding the Managed Services Model
UCD School of Medicine & Medical Science
Making MDTs better Steve Falk
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
Appropriateness of Coronary Revascularization for Patients Without Acute Coronary Syndromes Edward L. Hannan, PhD; Kimberly Cozzens, MA; Zaza Samadashvili,
ACC/SCAI – i2 Summit Late Breaking Clinical Trials March 29, 2008
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
Atlantic Cardiovascular Patient Outcomes Research Team
Office Or Outpatient Centers Are The Best Place To Perform Most Arterial And Venous Interventional Treatments: Precautions And Current Status Of Their.
Presentation transcript:

DGH v Tertiary Intervention Is there really a conflict? “The BCIS Perspective” Dr Martyn Thomas Kings College Hospital BCIS President

MY CONFLICTS OF INTEREST ARE: Research Support: Boston Scientific, Cordis and Medtronic Advisory Board for: Boston, Cordis, Abbott, Lilly and Nycomed.

DGH v Tertiary Intervention (p.s. surgical v non surgical centres!) Is there really a conflict? “The BCIS Perspective” What “experience” do I have to give such a talk? What “experience” do I have to give such a talk? - BCIS President - Currently perform PCI at Kings College Hospital (Teriary) AND the “Mayday Hospital” (DGH). Gives some perspective!!

DGH v Tertiary Intervention Is there really a conflict? “The BCIS Perspective” Where does the UK stand in worldwide terms with regard to revascularisation??

Total UK PCI Procedures 2005 data: Ludman

A worldwide perspective.

UK Centres data: Ludman

What are the current guidelines: for a new PCI centre?

What are the current guidelines: for an operator?

Number of PCIs performed in 2005 ( per NHS Centre) 2005 data: Ludman Data from: all 65 NHS centres Mean = 1028

Surgical Cover

Surgical cover

Year % Procedure Success % QMI % Re PCI for acute closure % Em. CABG Mortality (%) (51 of 64) 0.57 (49 of 64) 0.33 (50 of 64) 0.28 (53 of 64) (62 of 73) 0.36 (56 of 73) 0.17 (62 of 73) 0.29 (64 of 73) (63 of 78) 0.30 (57 of 78) 0.30 (61 of 78) 0.21 (64 of 78) 0.56 (66 of 78) MACE (2005) - All PCIs All Data from CCAD + Form C 2005 data: Ludman

Surgical Cover (all 83 NHS and Private Centres) On site Off site No of centres 54(65%)29(35%) No. of PCI (% of total) 57,545(82%)12,622(18%) Mean No. PCI per centre PCIs per interventionist (all 65 NHS centres only): data: Ludman

Tertiary (Surgical) and DGH (Non-Surgical) centres receiving BCIS visits since 2004 (the “Truth!”. 1:20 is a Surgical centre!

Tertiary (surgical centre) Paranoia Where is all the work? What will we do?

The Model (DOH) 3 levels of revascularisation tested; 1900, 2200 and 2500 per million, by levels of revascularisation tested; 1900, 2200 and 2500 per million, by % increase in ICDs, reaching latest NICE guidelines by % increase in ICDs, reaching latest NICE guidelines by A range of 5-15% increase in interventions for EP/arrythmias. A range of 5-15% increase in interventions for EP/arrythmias.

NB: BCS 2004 proposed per million for PCI alone!! NB: BCS 2004 proposed per million for PCI alone!!

The Model Revasc rates by 2015 PCI:CABG ratio /mill2.9:13.1:13.5:1 2200/mill3.2:13.4:14.2:1 2500/mill3.4:13.8:14.9:1

Where will PCI take place in the future?

Implications for cath lab capacity

Potential growth areas ? For the surgical centres “Hole” closure: PFO, ASD etc. “Hole” closure: PFO, ASD etc. Percutaneous Valve therapy. Percutaneous Valve therapy. Intramyocardial injection therapy Intramyocardial injection therapy “Gene/cell” therapy. “Gene/cell” therapy.

Specific “issues” with a change toward PCI in non-surgical centres (not outcome related!) Changes needed in the organisation of some interventional research. Changes needed in the organisation of some interventional research. Case Mix (the Tariff). Case Mix (the Tariff).

Interventional Research Consequences of a “devolved service” Currently a “handful” of surgical centres have the infra-structure, and perform international multicentre randomised trials and registries. Currently a “handful” of surgical centres have the infra-structure, and perform international multicentre randomised trials and registries. For FIM type cases this requires relatively straightforward lesions………..these will be increasingly rare in the surgical centres. For FIM type cases this requires relatively straightforward lesions………..these will be increasingly rare in the surgical centres. A change of infra-structure/research staff etc will therefore be necessary for this activity to continue. A change of infra-structure/research staff etc will therefore be necessary for this activity to continue.

The Tariff Problems of Case Mix E15: Percutaneous coronary intervention E15: Percutaneous coronary intervention Elective £3660 Elective £3660 Non-elective £4758 Non-elective £4758 CABG elective £7195 CABG elective £7195 CABG non elective £8748 CABG non elective £8748 Kings MFF 1.3 Kings MFF % uplift +16% uplift Leads to PCI elective=£5519 and PCI non elective=£7175 Leads to PCI elective=£5519 and PCI non elective=£7175

Tertiary centre: year cases referred from DGH 60% unstable and 40% stable 25% multiple stents Simple elective: make £500, Complex elective: lose £1000 Simple elective: make £500, Complex elective: lose £1000 Simple non-elective: make £1,500, Complex non- elective: lose 1,500 Simple non-elective: make £1,500, Complex non- elective: lose 1,500 Revenue: Revenue: Simple non-elective: +£67,500 Simple non-elective: +£67,500 Complex non-elective: -£22,500 Complex non-elective: -£22,500 Simple elective: +£15,000 Simple elective: +£15,000 Complex elective: -£10,000 Complex elective: -£10,000 Net income= +£50,000 Net income= +£50,000

Tertiary centre: year 2 25 cases referred from DGH (all complex), 75 cases done in non surgical centre. Non-surgical centre: Non-surgical centre: Simple non-elective: +£67,500 Simple non-elective: +£67,500 Simple complex: +£15,000 Simple complex: +£15,000 Revenue: +£82,500 Revenue: +£82,500 Tertiary centre: Tertiary centre: Complex non-elective: -£22,500 Complex non-elective: -£22,500 Complex elective: -£10,000 Complex elective: -£10,000 Revenue: -£32,500 Revenue: -£32,500

Potential consequences of the Tariff and non-surgical centre PCI. Potential diversion of revascularisation toward surgery because of “skewed” case mix leading to PCI being non-viable. Potential diversion of revascularisation toward surgery because of “skewed” case mix leading to PCI being non-viable. Potential of “profiteering” of DGH at the expense of Quality. Potential of “profiteering” of DGH at the expense of Quality.

Personnel view!! Fully supportive of non-surgical centre PCI, as long as volume and expertise are maintained. Fully supportive of non-surgical centre PCI, as long as volume and expertise are maintained. Here are the last x2 cases at the Mayday………….last Thursday. Here are the last x2 cases at the Mayday………….last Thursday.

Conclusions  Training and experience has more influence on outcome of PCI than location.  As long as individual and institutional volumes are maintained BCIS fully supports the development of non-surgical centre PCI.  Strong links between the surgical centre and non-surgical centre with exchange of personnel and audit data in both directions is essential.  Achievement of “European” type rates of revascularisation cannot be done without full use of the non-surgical cath labs.

Conclusions  Development of research infrastructure within the non-surgical centres should be encouraged.  Surgical centre operators should be encouraged to “support” non-surgical centres, including performing PCI sessions.  Some form of tariff sharing may be required across Networks to make all units viable and to avoid distortion of clinical practice for financial reasons.